Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Diabetes Technology & Therapeutics
|
February 24, 2007
AKA-TPG: a program for kinetic and epidemiological analysis of data from labeled glucose investigations using the two-pool model and database technology
Raymond C Boston, Darko Stefanovski, Jan E Henriksen, et al.
Journal of Hypertension
|
October 11, 2013
Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial
Christina S Oxlund, Jan E Henriksen, Lise Tarnow, et al.
Plos One
|
May 12, 2018
Critical-depth Raman spectroscopy enables home-use non-invasive glucose monitoring
Signe M Lundsgaard-Nielsen, Anders Pors, Stefan O Banke, et al.
Public Health Nutrition
|
November 11, 2014
Missing portion sizes in FFQ--alternatives to use of standard portions
Rasmus Køster-Rasmussen, Volkert Siersma, Thorhallur I Halldorsson, et al.
Diabetes Care
|
October 19, 2013
Metformin, but not rosiglitazone, attenuates the increasing plasma levels of a new cardiovascular marker, fibulin-1, in patients with type 2 diabetes
Vibe Skov, Claudia Cangemi, Jeppe Gram, et al.
Diabetes & Vascular Disease Research
|
August 7, 2014
Plasma copeptin as marker of cardiovascular disease in asymptomatic type 2 diabetes patients
Dana Bar-Shalom, Mikael K Poulsen, Lars M Rasmussen, et al.
Diabetes Care
|
January 29, 2021
A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes
Dorte Vistisen, Gregers S Andersen, Adam Hulman, et al.
Cardiovascular Diabetology
|
August 16, 2011
Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus
Mikael K Poulsen, Mads Nybo, Jordi Dahl, et al.
ACS Sensors
|
March 6, 2023
Accurate Post-Calibration Predictions for Noninvasive Glucose Measurements in People Using Confocal Raman Spectroscopy
Anders Pors, Kaspar G Rasmussen, Rune Inglev, et al.
Diabetes/Metabolism Research and Reviews
|
April 27, 2018
Pathophysiology-based phenotyping in type 2 diabetes: A clinical classification tool
Jacob V Stidsen, Jan E Henriksen, Michael H Olsen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Diabetes Technology & Therapeutics
|
February 24, 2007
AKA-TPG: a program for kinetic and epidemiological analysis of data from labeled glucose investigations using the two-pool model and database technology
Raymond C Boston, Darko Stefanovski, Jan E Henriksen, et al.
Journal of Hypertension
|
October 11, 2013
Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial
Christina S Oxlund, Jan E Henriksen, Lise Tarnow, et al.
Plos One
|
May 12, 2018
Critical-depth Raman spectroscopy enables home-use non-invasive glucose monitoring
Signe M Lundsgaard-Nielsen, Anders Pors, Stefan O Banke, et al.
Public Health Nutrition
|
November 11, 2014
Missing portion sizes in FFQ--alternatives to use of standard portions
Rasmus Køster-Rasmussen, Volkert Siersma, Thorhallur I Halldorsson, et al.
Diabetes Care
|
October 19, 2013
Metformin, but not rosiglitazone, attenuates the increasing plasma levels of a new cardiovascular marker, fibulin-1, in patients with type 2 diabetes
Vibe Skov, Claudia Cangemi, Jeppe Gram, et al.
Diabetes & Vascular Disease Research
|
August 7, 2014
Plasma copeptin as marker of cardiovascular disease in asymptomatic type 2 diabetes patients
Dana Bar-Shalom, Mikael K Poulsen, Lars M Rasmussen, et al.
Diabetes Care
|
January 29, 2021
A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes
Dorte Vistisen, Gregers S Andersen, Adam Hulman, et al.
Cardiovascular Diabetology
|
August 16, 2011
Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus
Mikael K Poulsen, Mads Nybo, Jordi Dahl, et al.
ACS Sensors
|
March 6, 2023
Accurate Post-Calibration Predictions for Noninvasive Glucose Measurements in People Using Confocal Raman Spectroscopy
Anders Pors, Kaspar G Rasmussen, Rune Inglev, et al.
Diabetes/Metabolism Research and Reviews
|
April 27, 2018
Pathophysiology-based phenotyping in type 2 diabetes: A clinical classification tool
Jacob V Stidsen, Jan E Henriksen, Michael H Olsen, et al.
Page
of 1